Literature DB >> 26640556

Clinical significance of dynamic monitoring of blood lactic acid, oxygenation index and C-reactive protein levels in patients with severe pneumonia.

Wei Liu1, Liping Peng1, Shucheng Hua1.   

Abstract

The aim of the present study was to analyze the clinical significance of the dynamic monitoring of blood lactic acid levels, the oxygenation index and C-reactive protein (CRP) levels in patients with severe pneumonia. The clinical data of 34 cases with severe pneumonia were collected. According to the clinical outcome, the patients were divided into a survival group (n=26) and a fatality group (n=8). Various factors, including the blood lactic acid level, oxygenation index, CRP level and acute physiology and chronic health evaluation II (APACHE II) score, were retrospectively analyzed in order to investigate whether these values had clinical significance for the prognosis of the patients. No statistically significant differences with regard to age, gender, initial concentrations of blood lactic acid and CRP, and APACHE II scores were observed between the two groups at admission to the Intensive Care Unit. However, the blood lactic acid levels were found to decrease to a normal level within 12-24 h after treatment in the survival group, while the levels were maintained at a higher concentration in the fatality group, even at 72 h after treatment (P<0.05). Furthermore, the oxygenation index in the survival group was significantly higher when compared with that in the fatality group. The oxygenation index was maintained at a normal level in the survival group, while the oxygenation index levels were below normal and continued to decline in the fatality group. A positive correlation was observed between the blood lactic acid level and the APACHE II scores (r=0.656, P<0.05). Therefore, the present study demonstrated that dynamic monitoring of blood lactic acid, oxygenation index and CRP levels in patients with severe pneumonia can be used to evaluate the therapeutic efficiency, in addition to serving as a prognosis indicator, for patients with severe pneumonia.

Entities:  

Keywords:  C-reactive protein; blood lactic acid; oxygenation index; severe pneumonia; systemic inflammation response syndrome

Year:  2015        PMID: 26640556      PMCID: PMC4665687          DOI: 10.3892/etm.2015.2770

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  25 in total

1.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

2.  Characterization of the inflammatory infiltrate in Streptococcus pneumoniae pneumonia in young and elderly patients.

Authors:  Thomas Menter; Carmen Giefing-Kroell; Beatrix Grubeck-Loebenstein; Alexandar Tzankov
Journal:  Pathobiology       Date:  2014-04-15       Impact factor: 4.342

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Tissue oxygenation in clinical medicine: an historical review.

Authors:  M J Miller
Journal:  Anesth Analg       Date:  1982-06       Impact factor: 5.108

Review 5.  Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review.

Authors:  Hazel-Ann Borthwick; Lorraine K Brunt; Kelly L Mitchem; Christopher Chaloner
Journal:  Ann Clin Biochem       Date:  2012-06-19       Impact factor: 2.057

Review 6.  Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis.

Authors:  J H James; F A Luchette; F D McCarter; J E Fischer
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

7.  Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill.

Authors:  Konrad Reinhart; Hans-Jörg Kuhn; Christiane Hartog; Donald L Bredle
Journal:  Intensive Care Med       Date:  2004-06-09       Impact factor: 17.440

Review 8.  [ECMO for the patients with severe respiratory failure associated with ARDS due to influenza].

Authors:  Katsuya Kobayashi; Shinhiro Takeda
Journal:  Masui       Date:  2013-05

9.  Early lactate clearance is associated with improved outcome in severe sepsis and septic shock.

Authors:  H Bryant Nguyen; Emanuel P Rivers; Bernhard P Knoblich; Gordon Jacobsen; Alexandria Muzzin; Julie A Ressler; Michael C Tomlanovich
Journal:  Crit Care Med       Date:  2004-08       Impact factor: 7.598

10.  Comparison of mixed venous oxygen saturation after in vitro calibration of pulmonary artery catheter with that of pulmonary arterial blood in patients undergoing living donor liver transplantation.

Authors:  K M Kim; J S Ko; M S Gwak; G S Kim; H S Cho
Journal:  Transplant Proc       Date:  2013-06       Impact factor: 1.066

View more
  7 in total

1.  High Mean Platelet Volume Associates with In-Hospital Mortality in Severe Pneumonia Patients.

Authors:  Jieru Chen; Yihao Li; Yingsi Zeng; Yu Tian; Yueqiang Wen; Zebin Wang
Journal:  Mediators Inflamm       Date:  2020-06-08       Impact factor: 4.711

2.  Comparison of pneumonia severity scores for patients diagnosed with pneumonia in emergency department.

Authors:  Aynur Ecevit Kaya; Seda Ozkan; Eren Usul; Engin Deniz Arslan
Journal:  Indian J Med Res       Date:  2020-10       Impact factor: 2.375

3.  Clinical characteristics and risk factors associated with mortality in patients with severe community-acquired pneumonia and type 2 diabetes mellitus.

Authors:  Dong Huang; Dingxiu He; Linjing Gong; Wen Wang; Lei Yang; Zhongwei Zhang; Yujun Shi; Zongan Liang
Journal:  Crit Care       Date:  2021-12-07       Impact factor: 9.097

4.  Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity.

Authors:  Pu Ning; Yali Zheng; Qiongzhen Luo; Xiaohui Liu; Yu Kang; Yan Zhang; Rongbao Zhang; Yu Xu; Donghong Yang; Wen Xi; Keqiang Wang; Yusheng Chen; Shuchang An; Zhancheng Gao
Journal:  Crit Care       Date:  2018-05-14       Impact factor: 9.097

5.  A Bayesian decision support sequential model for severity of illness predictors and intensive care admissions in pneumonia.

Authors:  Amado Alejandro Baez; Laila Cochon; Jose Maria Nicolas
Journal:  BMC Med Inform Decis Mak       Date:  2019-12-30       Impact factor: 2.796

6.  Clinical Role of Serum Interleukin-17A in the Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Jiuling Zhao; Xin Ji; Yushui Wang; Xin Wang
Journal:  Infect Drug Resist       Date:  2020-03-12       Impact factor: 4.003

7.  Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges.

Authors:  Ahmed E Abou Warda; Rania M Sarhan; Hussein Saeed Al-Fishawy; Ayman N Moharram; Heba F Salem
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.